Xellia Pharmaceuticals USA LLC FDA Inspection Record
Xellia Pharmaceuticals USA LLC is an FDA-inspected facility (FEI 3012279857) located in Bedford, OH, US. RegDataLab tracks 5 FDA inspections and 1 compliance action at this facility.
What FDA found at this site
- Latest inspection
- Sep 29, 2023: Voluntary Action Indicated (VAI)
- Inspections on record
- 5 (4 VAI, 1 NAI)
- Last OAI inspection
- None on record
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Sep 29, 2023 | Voluntary Action Indicated (VAI) | Validation lacking for sterile drug products (21 CFR 211.113(b)) Written record of investigation incomplete (21 CFR 211.192) |
| Dec 15, 2022 | Voluntary Action Indicated (VAI) | No citations listed |
| Feb 7, 2022 | Voluntary Action Indicated (VAI) | Procedures not in writing, fully followed (21 CFR 211.22(d)) |
| Jan 31, 2020 | Voluntary Action Indicated (VAI) | No citations listed |
| Oct 13, 2016 | No Action Indicated (NAI) | No citations listed |
FDA record score
11 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
4 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Inspection classified VAI | Sep 29, 2023 | 6 x 0.6 | 3.6 |
| Inspection classified VAI | Dec 15, 2022 | 6 x 0.6 | 3.6 |
| Inspection classified VAI | Feb 7, 2022 | 6 x 0.6 | 3.6 |
| Inspection classified VAI | Jan 31, 2020 | Only the 3 most recent VAI inspections add points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 22, 2026 | Newest record Nov 9, 2026 | Current |
| Inspection citations | Nov 22, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 22, 2026 | Newest record Nov 13, 2026 | Current |
| Warning letter text | Nov 22, 2026 | Newest record Nov 17, 2026 | Current |
| Recalls (Enforcement Report) | Nov 22, 2026 | Newest record Nov 18, 2026 | Current |
| Form 483s and inspection documents | Nov 18, 2026 | Newest record Nov 17, 2026 | Current |
| Import refusals | Nov 22, 2026 | Newest record Nov 12, 2026 | Current |
Reviewing Xellia Pharmaceuticals USA LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Xellia Pharmaceuticals USA LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Hikma Pharmaceuticals USA Inc.
- Location
- Bedford, OH (US)
- Source
- inspections